|
|
||||||||
Clinical Chemistry, Vol 39, 72-75, Copyright © 1993 by American Association for Clinical Chemistry
MM Reidenberg, ZP Gu, B Lorenzo, E Coutinho, C Athayde, J Frick, F Alvarez, V Brache and EE Emuveyan
Department of Pharmacology and Medicine, Cornell University Medical College, New York, NY 10021.
Hypokalemia has been associated with the taking of gossypol, a potential oral antifertility drug for men. Because the frequency of this response differed in different parts of the world, this study was done to learn if "normal" serum [K+] also differed. [K+] was measured by flame photometry in serum from apparently normal men from Austria (n = 30), China (53), Brazil (100), the Dominican Republic (38), and the US (103), and in plasma from Nigerian men (82). The mean (SD) for [K+] in Chinese men, 3.82 (0.27) mmol/L, was lower than that in Brazilians [4.06 (0.29) mmol/L], Austrians [4.14 (0.44) mmol/L], Dominicans [4.37 (0.33) mmol/L], or Americans [4.38 (0.37) mmol/L]. Apparently there are regional differences in average serum [K+], with men in China having lower serum [K+] than men elsewhere. This may predispose them to hypokalemia.
The following articles in journals at HighWire Press have cited this article:
![]() |
A O K Chan, K C Lee, J N S Leung, and C C Shek Reference intervals of common serum analytes of Hong Kong Chinese J. Clin. Pathol., May 1, 2008; 61(5): 632 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ichihara, Y. Itoh, C. W. K. Lam, P. M. K. Poon, J.-H. Kim, H. Kyono, N. Chandrawening, D. Muliaty, and Science Committee for the Asian-Pacific Federation Sources of Variation of Commonly Measured Serum Analytes in 6 Asian Cities and Consideration of Common Reference Intervals Clin. Chem., February 1, 2008; 54(2): 356 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Qiu, L. R. Levin, J. Buck, and M. M. Reidenberg Different Pathways of Cell Killing by Gossypol Enantiomers Experimental Biology and Medicine, June 1, 2002; 227(6): 398 - 401. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |